Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

This study has been completed.
Sponsor:
Collaborator:
Bayer
Information provided by:
Regeneron Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00320775
First received: April 28, 2006
Last updated: June 8, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)